-
Jennerex Biotherapeutics, Inc. (now
owned by SillaJen) was an
American private biopharmaceutical company that
developed the
oncolytic viruses JX-594 and...
-
Cancer Institute for JX-594. 2003.
Jennerex, Inc. (San Francisco, USA) was established. 2014.
SillaJen acquires Jennerex, Inc. 2015. In
April 2015. SillaJen...
- (1992–2012)
James Woolley, Sons and Co. (1833–1962)
Jenapharm (1950–2001)
Jennerex (2003–2014)
Jerini (1994–2009) Juno (2013–2018) King (1993–2010) Knoll...
-
Canadian cancer researcher, co-founder and
chief scientific officer of
Jennerex Eric
Hoskins BSc 1982, MD 1984
Former Minister of
Health in Ontario, founder...
-
University of
Ottawa Bell is the co-founder and
chief scientific officer of
Jennerex, Inc.,
which is a
biotech company in San
Francisco that is
producing oncolytic...
-
vaccine company that he sold to Pfizer. Kirn was also
founder and CEO of
Jennerex (2003–2013) and was the
first development employee and vice
president of...
- needed] Un
virus contre le
cancer 25
March 2012,
Radio Canada (in French)
Jennerex Granted FDA
Orphan Drug
Designation for Pexa-Vec in
Hepatocellular Carcinoma...
